Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019)

Adaptive Biotechnologies has reported Preferred Stock Liabilities for 2 years, with the latest figure at $561.9 million in Q2 2019.

• Quarterly Preferred Stock Liabilities changed 0.23% year-over-year to $561.9 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $561.9 million (changed 0.23% YoY) and the FY2018 annual result came in at $560.9 million, changed 0.08% from the prior year.
• Preferred Stock Liabilities was little changed at $561.9 million in Q2 2019 per ADPT's latest filing, from $561.2 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $561.9 million in Q2 2019 and troughed at $560.7 million in Q2 2018.